193 related articles for article (PubMed ID: 26371475)
21. Human embryonic kidney cells (HEK-293 cells): characterization and dose-response relationship for modulated release of nerve growth factor for nerve regeneration.
Jimenez JC; Tyson DR; Dhar S; Nguyen T; Hamai Y; Bradshaw RA; Evans GR
Plast Reconstr Surg; 2004 Feb; 113(2):605-10. PubMed ID: 14758223
[TBL] [Abstract][Full Text] [Related]
22. Nerve growth factor in metabolic complications and Alzheimer's disease: Physiology and therapeutic potential.
Ding XW; Li R; Geetha T; Tao YX; Babu JR
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165858. PubMed ID: 32531260
[TBL] [Abstract][Full Text] [Related]
23. Structural and functional properties of mouse proNGF.
Paoletti F; Konarev PV; Covaceuszach S; Schwarz E; Cattaneo A; Lamba D; Svergun DI
Biochem Soc Trans; 2006 Aug; 34(Pt 4):605-6. PubMed ID: 16856872
[TBL] [Abstract][Full Text] [Related]
24. Production of functional human nerve growth factor from the submandibular glands of mice using a CRISPR/Cas9 genome editing system.
Gu Y; Cao H; Li F; Yu J; Nian R; Feng D; Lin J; Song H; Liu W
World J Microbiol Biotechnol; 2020 Oct; 36(12):176. PubMed ID: 33103226
[TBL] [Abstract][Full Text] [Related]
25. Conformational characterization of nerve growth factor-β reveals that its regulatory pro-part domain stabilizes three loop regions in its mature part.
Trabjerg E; Kartberg F; Christensen S; Rand KD
J Biol Chem; 2017 Oct; 292(40):16665-16676. PubMed ID: 28798232
[TBL] [Abstract][Full Text] [Related]
26. Neurotrophic activity of proNGF in vivo.
Buttigieg H; Kawaja MD; Fahnestock M
Exp Neurol; 2007 Apr; 204(2):832-5. PubMed ID: 17270174
[TBL] [Abstract][Full Text] [Related]
27. Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA.
Colquhoun A; Lawrance GM; Shamovsky IL; Riopelle RJ; Ross GM
J Pharmacol Exp Ther; 2004 Aug; 310(2):505-11. PubMed ID: 15051797
[TBL] [Abstract][Full Text] [Related]
28. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.
Fahnestock M; Michalski B; Xu B; Coughlin MD
Mol Cell Neurosci; 2001 Aug; 18(2):210-20. PubMed ID: 11520181
[TBL] [Abstract][Full Text] [Related]
29. Generation and transplantation of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice.
Carpenter MK; Winkler C; Fricker R; Emerich DF; Wong SC; Greco C; Chen EY; Chu Y; Kordower JH; Messing A; Björklund A; Hammang JP
Exp Neurol; 1997 Nov; 148(1):187-204. PubMed ID: 9398461
[TBL] [Abstract][Full Text] [Related]
30. Understanding pain perception through genetic painlessness diseases: The role of NGF and proNGF.
Testa G; Cattaneo A; Capsoni S
Pharmacol Res; 2021 Jul; 169():105662. PubMed ID: 34000361
[TBL] [Abstract][Full Text] [Related]
31. ProNGF: a neurotrophic or an apoptotic molecule?
Fahnestock M; Yu G; Coughlin MD
Prog Brain Res; 2004; 146():101-10. PubMed ID: 14699959
[TBL] [Abstract][Full Text] [Related]
32. Expression of NGF, Trka and p75 in human cartilage.
Gigante A; Bevilacqua C; Pagnotta A; Manzotti S; Toesca A; Greco F
Eur J Histochem; 2003; 47(4):339-44. PubMed ID: 14706929
[TBL] [Abstract][Full Text] [Related]
33. The nerve growth factor administrated as eye drops activates mature and precursor cells in subventricular zone of adult rats.
Tirassa P
Arch Ital Biol; 2011 Jun; 149(2):205-13. PubMed ID: 21701992
[TBL] [Abstract][Full Text] [Related]
34. In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression.
Lambiase A; Micera A; Pellegrini G; Merlo D; Rama P; De Luca M; Bonini S; Bonini S
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4622-30. PubMed ID: 19407015
[TBL] [Abstract][Full Text] [Related]
35. Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.
Dedoni S; Olianas MC; Ingianni A; Onali P
Neuropharmacology; 2014 Apr; 79():321-34. PubMed ID: 24333329
[TBL] [Abstract][Full Text] [Related]
36. In vivo induction and delivery of nerve growth factor, using HEK-293 cells.
McConnell MP; Dhar S; Naran S; Nguyen T; Bradshaw RA; Evans GR
Tissue Eng; 2004; 10(9-10):1492-501. PubMed ID: 15588408
[TBL] [Abstract][Full Text] [Related]
37. A small linear peptide encompassing the NGF N-terminus partly mimics the biological activities of the entire neurotrophin in PC12 cells.
Travaglia A; Pietropaolo A; Di Martino R; Nicoletti VG; La Mendola D; Calissano P; Rizzarelli E
ACS Chem Neurosci; 2015 Aug; 6(8):1379-92. PubMed ID: 25939060
[TBL] [Abstract][Full Text] [Related]
38. Dynamic structure of NGF and proNGF complexed with p75NTR: pro-peptide effect.
Pimenta AC; Dourado DF; Martins JM; Melo A; Dias Soeiro Cordeiro MN; Almeida RD; Morra G; Moreira IS
J Chem Inf Model; 2014 Jul; 54(7):2051-67. PubMed ID: 24941229
[TBL] [Abstract][Full Text] [Related]
39. β-Nerve growth factor attenuates hepatocyte injury induced by D-galactosamine in vitro via TrkA NGFR.
Li JF; Shu JC; Tang SH; Deng YM; Fu MY; Lv X
Mol Med Rep; 2013 Sep; 8(3):813-7. PubMed ID: 23864198
[TBL] [Abstract][Full Text] [Related]
40. Probing the structure-function relationship of nerve growth factor.
Vroegop S; Decker D; Hinzmann J; Poorman R; Buxser S
J Protein Chem; 1992 Feb; 11(1):71-82. PubMed ID: 1325153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
